What is he best known for?
The fields of study he is best known for:
- Immune system
- Gene
- Cytokine
His main research concerns Immunology, T cell, Cytotoxic T cell, Cell biology and Interleukin 21.
His Immunology research includes elements of Molecular biology and CD40.
His T cell study combines topics in areas such as Apoptosis, Senescence, Cell aging and Stromal cell.
His Cell biology study incorporates themes from Cancer research, CD28, CD8, T-cell receptor and Telomere.
His Interleukin 21 study combines topics from a wide range of disciplines, such as Natural killer T cell, Interleukin 12 and IL-2 receptor.
His Immune system research is multidisciplinary, incorporating perspectives in Inflammation and Cytokine.
His most cited work include:
- Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells. (778 citations)
- Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. (485 citations)
- Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. (436 citations)
What are the main themes of his work throughout his whole career to date?
Arne N. Akbar spends much of his time researching Immunology, Cytotoxic T cell, T cell, Cell biology and Immune system.
As part of his studies on Immunology, he often connects relevant subjects like Molecular biology.
His study in Interleukin 21, Natural killer T cell, Antigen-presenting cell and CD28 falls under the purview of Cytotoxic T cell.
The concepts of his Interleukin 21 study are interwoven with issues in Interleukin 12, IL-2 receptor and CD40.
His T cell research is multidisciplinary, relying on both Senescence, Lymphocyte and Effector.
Arne N. Akbar focuses mostly in the field of Cell biology, narrowing it down to topics relating to Apoptosis and, in certain cases, Cancer research.
He most often published in these fields:
- Immunology (63.69%)
- Cytotoxic T cell (28.34%)
- T cell (26.43%)
What were the highlights of his more recent work (between 2013-2021)?
- Immunology (63.69%)
- Immune system (24.52%)
- Cell biology (25.80%)
In recent papers he was focusing on the following fields of study:
Arne N. Akbar mostly deals with Immunology, Immune system, Cell biology, T cell and Cytotoxic T cell.
Inflammation, Vaccination, Varicella zoster virus, Antigen and Immunity are the subjects of his Immunology studies.
His study in the field of Innate immune system, Immunosenescence and Acquired immune system is also linked to topics like Context and Text mining.
His research integrates issues of Senescence, CD8 and MAPK/ERK pathway in his study of T cell.
Arne N. Akbar has included themes like Receptor, Cell, Cell aging and Melanoma in his Cytotoxic T cell study.
As a part of the same scientific study, Arne N. Akbar usually deals with the Signal transduction, concentrating on Cytokine secretion and frequently concerns with Lymphokine-activated killer cell and Interleukin 21.
Between 2013 and 2021, his most popular works were:
- Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin (413 citations)
- p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8+ T cells (157 citations)
- The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells. (146 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Gene
- Cytokine
Arne N. Akbar mainly focuses on Immunology, Immune system, Cell biology, CD8 and T cell.
His research on Immunology often connects related areas such as Pathology.
His Immune system research integrates issues from Antigen and Vaccination.
His studies link Cytotoxic T cell with CD8.
His study in Cytotoxic T cell is interdisciplinary in nature, drawing from both Tumor necrosis factor alpha, Cell signaling, Signal transduction, Cancer research and Cellular differentiation.
His T cell study deals with Senescence intersecting with Cytokine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
